Literature DB >> 25854856

Physicochemical and crystal structure analysis of pranlukast pseudo-polymorphs II: Solvate and cocrystal.

Hideaki Furuta1, Shintaro Mori2, Yasuo Yoshihashi1, Etsuo Yonemochi3, Hidehiro Uekusa2, Kiyohiko Sugano4, Katsuhide Terada1.   

Abstract

Pranlukast (PRS) is a leukotriene receptor antagonist for the treatment of bronchial asthma. In this study, six new solvates and one new cocrystal of PRS were characterized by PXRD, TG-DTA, DSC, vapor sorption analysis and the dissolution test. In addition, the crystal structures were determined by single crystal X-ray structure analysis. PRS was found to be a rare example of a promiscuous multicomponent crystal former. The crystal packing patterns of these crystals can be categorized into the sheet-like and channel-like patterns. The ethanol solvate (PRS/ethanol) and urea cocrystal (PRS/urea) were more stable than the others under humid conditions. PRS/ethanol showed an improved dissolution profile compared to PRS HH and PRS/urea.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Crystal structure; Dissolution; Pranlukast; Pseudo-polymorph; Vapor sorption

Mesh:

Substances:

Year:  2015        PMID: 25854856     DOI: 10.1016/j.jpba.2015.03.008

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  1 in total

1.  Epalrestat tetra-hydro-furan monosolvate: crystal structure and phase transition.

Authors:  Daiki Umeda; Okky Dwichandra Putra; Mihoko Gunji; Kaori Fukuzawa; Etsuo Yonemochi
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2017-06-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.